Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders (Q28273607)

Glutamate receptor dynamics in dendritic microdomains

Europe PubMed Central

title

Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders (English)

0 references

author name string

Andrei G Malykh

series ordinal

1

0 references

M Reza Sadaie

series ordinal

2

0 references

language of work or name

English

0 references

publication date

12 February 2010

0 references

published in

Drugs

0 references

volume

70

0 references

issue

3

0 references

page(s)

287-312

0 references

cites work

1 reference

12 December 2020

Clinical trials in mild cognitive impairment: lessons for the future

1 reference

12 December 2020

Piracetam prevents cognitive decline in coronary artery bypass: a randomized trial versus placebo.

1 reference

12 December 2020

An open-label study of levetiracetam for the treatment of social anxiety disorder

1 reference

12 December 2020

The effects of L-carnitine on the combination of, inhalation anesthetic-induced developmental, neuronal apoptosis in the rat frontal cortex

1 reference

12 December 2020

A study to assess the anticholinergic activity of rolipram in healthy elderly volunteers

1 reference

12 December 2020

In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine

1 reference

12 December 2020

Design and Study of Piracetam-like Nootropics, Controversial Members of the Problematic Class of Cognition-Enhancing Drugs

1 reference

12 December 2020

MKC-231, a choline-uptake enhancer: (1) long-lasting cognitive improvement after repeated administration in AF64A-treated rats

1 reference

12 December 2020

Efficacy and tolerance of aniracetam in elderly patients with primary or secondary mental deterioration

1 reference

12 December 2020

Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105

1 reference

12 December 2020

Effects of a cholinergic nootropic (WEB 1881 FU) on event-related potentials recorded in incidental and intentional memory tasks

1 reference

12 December 2020

Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats

1 reference

12 December 2020

Pharmacokinetics of pramiracetam in healthy volunteers after oral administration

1 reference

12 December 2020

Pharmacokinetics of aniracetam and its metabolites in rats

1 reference

12 December 2020

The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men

1 reference

12 December 2020

Placebo-controlled study of pramiracetam in young males with memory and cognitive problems resulting from head injury and anoxia

1 reference

12 December 2020

The phenotropil treatment of the consequences of brain organic lesions

1 reference

12 December 2020

Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures

1 reference

12 December 2020

Pharmacokinetics of the antidepressant rolipram in healthy volunteers

1 reference

12 December 2020

Metabolic disposition of Rolziracetam in laboratory animals

1 reference

12 December 2020

Effect of Piracetam on electrocorticogram and local cerebral glucose utilization in the rat.

1 reference

12 December 2020

Nootropic drugs positively modulate alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-sensitive glutamate receptors in neuronal cultures

1 reference

12 December 2020

[The clinical and immunological aspects of the effects of phenotropil on consequences of stroke]

1 reference

12 December 2020

The effect of piracetam on ataxia: clinical observations in a group of autosomal dominant cerebellar ataxia patients

1 reference

12 December 2020

Aniracetam tested in chronic psychosyndrome after long-term exposure to organic solvents. A randomized, double-blind, placebo-controlled cross-over study with neuropsychological tests

1 reference

12 December 2020

Acetyl-L-carnitine ameliorates hypobaric hypoxic impairment and spatial memory deficits in rats

1 reference

12 December 2020

Synthesis and biological evaluation of novel dimiracetam derivatives useful for the treatment of neuropathic pain

1 reference

12 December 2020

Administration of phosphodiesterase inhibitors and an adenosine A1 receptor antagonist induces phrenic nerve recovery in high cervical spinal cord injured rats

1 reference

12 December 2020

Double-Blind Treatment of Apathy in Patients with Poststroke Depression Using Nefiracetam

1 reference

12 December 2020

Pharmacological characteristics of a new phenyl analog of piracetam--4-phenylpiracetam

1 reference

12 December 2020

Levetiracetam for treatment-refractory posttraumatic stress disorder.

1 reference

12 December 2020

Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients.

1 reference

12 December 2020

[The efficacy of phenotropil in the complex treatment of epilepsy]

1 reference

12 December 2020

1 reference

12 December 2020

Nefiracetam potentiates N-methyl-D-aspartate (NMDA) receptor function via protein kinase C activation and reduces magnesium block of NMDA receptor

1 reference

12 December 2020

Treatment trial of oxiracetam in Alzheimer's disease.

1 reference

12 December 2020

Rolipram versus imipramine in inpatients with major, "minor" or atypical depressive disorder: a double-blind double-dummy study aimed at testing a novel therapeutic approach

1 reference

12 December 2020

Piracetam affects facilitatory I-wave interaction in the human motor cortex

1 reference

12 December 2020

In-patient major depression: is rolipram as effective as amitriptyline?

1 reference

12 December 2020

Glutamate receptor ligands.

1 reference

12 December 2020

Alzheimer's disease-related alterations in synaptic density: neocortex and hippocampus.

1 reference

12 December 2020

Synthesis and pharmacological activity of a series of dihydro-1H-pyrrolo[1,2-a]imidazole-2,5(3H,6H)-diones, a novel class of potent cognition enhancers

1 reference

12 December 2020

Effect of the novel high affinity choline uptake enhancer 2-(2-oxopyrrolidin-1-yl)-N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b] quinolin-4-yl)acetoamide on deficits of water maze learning in rats

1 reference

12 December 2020

Pharmacokinetics of NS-105, a novel cognition enhancer. 2nd communication: distribution and transfer into fetus and milk after single administration, and effects of repeated administration on pharmacokinetics and hepatic drug-metabolizing enzyme act

1 reference

12 December 2020

Pharmacokinetic study of aniracetam in elderly patients with cerebrovascular disease

1 reference

12 December 2020

Impact of levetiracetam on mood and cognition during prednisone therapy.

1 reference

12 December 2020

Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin

1 reference

12 December 2020

Cerebroprotective effect of piracetam in patients undergoing coronary bypass burgery.

1 reference

12 December 2020

Sequelae of closed craniocerebral trauma and the efficacy of piracetam in its treatment in adolescents.

1 reference

12 December 2020

Involvement of metabotropic glutamate receptors in Gi- and Gs-dependent modulation of adenylate cyclase activity induced by a novel cognition enhancer NS-105 in rat brain.

1 reference

12 December 2020

Effect of the acquisition-enhancing drug piracetam on rat cerebral energy metabolism. Comparison with naftidrofuryl and methamphetamine

1 reference

12 December 2020

Experience of the out-patient use of memotropil in the treatment of cognitive disorders in patients with chronic progressive cerebrovascular disorders

1 reference

12 December 2020

Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study

1 reference

12 December 2020

Effects of acute doses of oxiracetam in the scopolamine model of human amnesia

1 reference

12 December 2020

Pharmacokinetics of oxiracetam following intravenous and oral administration in healthy volunteers

1 reference

12 December 2020

Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.

1 reference

12 December 2020

Experience in the application of pramistar, a new nootropic preparation, in the treatment of memory disorders in patients with cerebrovascular pathology

1 reference

12 December 2020

A systematic review and meta-analysis of the efficacy of piracetam and piracetam-like compounds in experimental stroke

1 reference

12 December 2020

A novel cognition enhancer NS-105 modulates adenylate cyclase activity through metabotropic glutamate receptors in primary neuronal culture.

1 reference

12 December 2020

Amnesia-reversal activity of a series of cyclic imides

1 reference

12 December 2020

Modulation of AMPA receptors in cultured cortical neurons induced by the antiepileptic drug levetiracetam

1 reference

12 December 2020

Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs

1 reference

12 December 2020

The "nootropic" approach to the pharmacology of the integrative activity of the brain

1 reference

12 December 2020

Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus.

1 reference

12 December 2020

Piracetam therapy does not enhance cognitive functioning in children with down syndrome

1 reference

12 December 2020

Clinical efficacy of piracetam in cognitive impairment: a meta-analysis

1 reference

12 December 2020

Nootropic drug modulation of neuronal nicotinic acetylcholine receptors in rat cortical neurons

1 reference

12 December 2020

Reverse Na+/Ca2+ exchange contributes to glutamate-induced intracellular Ca2+ concentration increases in cultured rat forebrain neurons

1 reference

12 December 2020

The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy males

1 reference

12 December 2020

Acetyl-L-carnitine in neuropathic pain: experimental data.

1 reference

12 December 2020

MKC-231, a choline uptake enhancer: (3) Mode of action of MKC-231 in the enhancement of high-affinity choline uptake

1 reference

12 December 2020

Calcium and neurodegeneration

1 reference

12 December 2020

Piracetam in acute stroke: a systematic review

1 reference

12 December 2020

The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery

1 reference

12 December 2020

Long-term efficacy and safety of piracetam in the treatment of progressive myoclonus epilepsy

1 reference

12 December 2020

Effect of fezam on ocular dynamics in patients with senile macular degeneration

1 reference

12 December 2020

Involvement of calpain in AMPA-induced toxicity to rat cerebellar Purkinje neurons

1 reference

12 December 2020

Piracetam elevates muscarinic cholinergic receptor density in the frontal cortex of aged but not of young mice

1 reference

12 December 2020

Piracetam: physiological disposition and mechanism of action

1 reference

12 December 2020

Effect of pyracetam on the color discriminative function of retina in patients with craniocerebral trauma

1 reference

12 December 2020

Characteristics of the formation of chronic fatigue syndrome and approaches to its treatment in young patients with focal brain damage

1 reference

12 December 2020

Effect of a novel cognition enhancer NS-105 on learned helplessness in rats: possible involvement of GABA(B) receptor up-regulation after repeated treatment.

1 reference

12 December 2020

Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme

1 reference

12 December 2020

The role of neurogenesis in neurodegenerative diseases and its implications for therapeutic development.

1 reference

12 December 2020

Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII)

1 reference

12 December 2020

The safety of levetiracetam

1 reference

12 December 2020

A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder

1 reference

12 December 2020

Effect of nebracetam on the disruption of spatial cognition in rats

1 reference

12 December 2020

Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical study

1 reference

12 December 2020

Activation of calpain I converts excitotoxic neuron death into a caspase-independent cell death

1 reference

12 December 2020

Pramiracetam effects on scopolamine-induced amnesia in healthy volunteers.

1 reference

12 December 2020

Changes in calcium dynamics following the reversal of the sodium-calcium exchanger have a key role in AMPA receptor-mediated neurodegeneration via calpain activation in hippocampal neurons

1 reference

12 December 2020

The hippocampus and memory: insights from spatial processing

1 reference

12 December 2020

Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine

1 reference

12 December 2020

A pilot study transitioning children onto levetiracetam monotherapy to improve language dysfunction associated with benign rolandic epilepsy

1 reference

12 December 2020

Brivaracetam: a new drug in development for epilepsy and neuropathic pain

1 reference

12 December 2020

Single- and multiple-dose pharmacokinetics of nefiracetam, a new nootropic agent, in healthy volunteers

1 reference

12 December 2020

Synaptic plasticity, memory and the hippocampus: a neural network approach to causality.

1 reference

12 December 2020

Pharmacokinetics of oral pramiracetam in normal volunteers

1 reference

12 December 2020

Nootropic drugs and brain cholinergic mechanisms

1 reference

12 December 2020

Seletracetam (UCB 44212)

1 reference

12 December 2020

1 reference

12 December 2020

Seletracetam, a small molecule SV2A modulator for the treatment of epilepsy

1 reference

12 December 2020

A pilot trial of piracetam and ginkgo biloba for the treatment of cocaine dependence

1 reference

12 December 2020

Neurotensin receptor mechanisms and its modulation of glutamate transmission in the brain: relevance for neurodegenerative diseases and their treatment.

1 reference

12 December 2020

[Use of phenotropil in the treatment of asthenic syndrome and autonomic disturbances in the acute period of mild cranial brain trauma]

1 reference

12 December 2020

Application of nootropic agents in complex treatment of patients with concussion of the brain

1 reference

12 December 2020

Effect of levetiracetam on depression and anxiety in adult epileptic patients

1 reference

12 December 2020

A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder

1 reference

12 December 2020

Effect of piracetam on cognitive performance in patients undergoing bypass surgery

1 reference

12 December 2020

Brivaracetam: a rational drug discovery success story

1 reference

12 December 2020

[Phenotropil in the treatment of vascular encephalopathy]

1 reference

12 December 2020

Nebracetam (WEB 1881FU) Prevents N-Methyl-D-Aspartate Receptor-Mediated Neurotoxicity in Rat Striatal Slices

1 reference

12 December 2020

Selective blockade of N-type calcium channels by levetiracetam

1 reference

12 December 2020

Histological evidence for neuroprotective action of nebracetam on ischemic neuronal injury in the hippocampus of stroke-prone spontaneously hypertensive rats

1 reference

12 December 2020

Double-blind randomized treatment of poststroke depression using nefiracetam

1 reference

12 December 2020

Effect of piracetam on ECT-induced cognitive disturbances: a randomized, placebo-controlled, double-blind study

1 reference

12 December 2020

Treatment of cognitive impairment secondary to degenerative dementia. Effectiveness of oxiracetam therapy

1 reference

12 December 2020

How can antiepileptic drugs affect bone mass, structure and metabolism? Lessons from animal studies

1 reference

12 December 2020

Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood--brain barrier disruption in multiple sclerosis

1 reference

12 December 2020

MKC-231, a choline uptake enhancer: (2) Effect on synthesis and release of acetylcholine in AF64A-treated rats

1 reference

12 December 2020

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

1 reference

12 December 2020

Mechanisms of action of cognitive enhancers on neuroreceptors

1 reference

12 December 2020

Clinical effect of WEB 1881 (nebracetam fumarate) on patients with dementia of the Alzheimer type and study of its clinical pharmacology.

1 reference

12 December 2020

Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine

1 reference

12 December 2020

Inhibitory action of nebracetam on various stimuli-evoked increases in intracellular Ca2+ concentrations in cultured rat cerebellar granule cells

1 reference

12 December 2020

Comparison of pharmacokinetics of NS-105, a novel agent for cerebrovascular disease, in elderly and young subjects.

1 reference

12 December 2020

[Complex treatment of epilepsy with phenotropil]

1 reference

12 December 2020

Double-Blind Randomized Treatment of Poststroke Depression Using Nefiracetam

1 reference

12 December 2020

Double-blind treatment of apathy in patients with poststroke depression using nefiracetam

1 reference

12 December 2020